Stats
Reporting of adverse events (August 5, 2005).
Most Institutional Review Boards (IRBs) have difficulty coping with the volume of adverse
events that study sponsors report to them. The FDA held a public meeting about this issue
recently, and some written responses are available as PDF files at the following location:
07/08/2008.
Category: Adverse events in clinical trials
